E. Razis

1.2k total citations
20 papers, 76 citations indexed

About

E. Razis is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Razis has authored 20 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Razis's work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). E. Razis is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). E. Razis collaborates with scholars based in Greece, United States and Cyprus. E. Razis's co-authors include George Fountzilas, Gerasimos Aravantinos, Anna Kalogera‐Fountzila, Maria Karina, Meletios Α. Dimopoulos, Perry Cook, Abraham Mittelman, Mattheos Bobos, Panagiotis Selviaridis and Despina Misailidou and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E. Razis

17 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Razis Greece 5 27 26 24 19 18 20 76
Birutė Brasiūnienė Lithuania 8 71 2.6× 25 1.0× 38 1.6× 17 0.9× 10 0.6× 27 126
Alvaro G. Menendez United States 5 33 1.2× 18 0.7× 14 0.6× 4 0.2× 14 0.8× 15 85
A. Winship United Kingdom 4 34 1.3× 25 1.0× 21 0.9× 6 0.3× 9 0.5× 7 93
A. Poveda Velasco Spain 6 21 0.8× 31 1.2× 37 1.5× 45 2.4× 2 0.1× 8 112
Ariel Ann Nelson United States 6 65 2.4× 50 1.9× 21 0.9× 6 0.3× 5 0.3× 28 111
Usama Al‐Jumaily Jordan 7 21 0.8× 38 1.5× 65 2.7× 12 0.6× 22 1.2× 14 134
Antoine Martin France 6 44 1.6× 17 0.7× 60 2.5× 40 2.1× 10 0.6× 12 153
Claire Briandet France 5 14 0.5× 5 0.2× 27 1.1× 4 0.2× 21 1.2× 8 59

Countries citing papers authored by E. Razis

Since Specialization
Citations

This map shows the geographic impact of E. Razis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Razis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Razis more than expected).

Fields of papers citing papers by E. Razis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Razis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Razis. The network helps show where E. Razis may publish in the future.

Co-authorship network of co-authors of E. Razis

This figure shows the co-authorship network connecting the top 25 collaborators of E. Razis. A scholar is included among the top collaborators of E. Razis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Razis. E. Razis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sgouros, Joseph, Gerasimos Aravantinos, Georgia-Angeliki Koliou, et al.. (2020). First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study. Anticancer Research. 40(2). 929–938. 6 indexed citations
3.
Fountzilas, Elena, Georgia-Angeliki Koliou, Vasiliki Rapti, et al.. (2019). Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting. Annals of Oncology. 30. v118–v118. 1 indexed citations
4.
Razis, E., Ioannis Kotsantis, Kyriaki Manousou, et al.. (2018). Evaluation of the effect of CXCL13 mRNA expression in early breast cancer outcome: A confirmatory study.. Journal of Clinical Oncology. 36(15_suppl). e24286–e24286. 3 indexed citations
5.
Koutras, Αngelos, Flora Zagouri, Georgia-Angeliki Koliou, et al.. (2018). Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes.. Journal of Clinical Oncology. 36(15_suppl). 1089–1089. 1 indexed citations
6.
Rigakos, George S., Anastasios Kyriazoglou, P. Nomikos, et al.. (2017). Bevacizumab in high grade glioma: Is there a subgroup that benefits?. 2(4). 1 indexed citations
7.
Koutras, Αngelos, Vassiliki Kotoula, G. Kouvatseas, et al.. (2016). Evaluation of the association of HER family members with efficacy of trastuzumab therapy in metastatic breast cancer. Annals of Oncology. 27. vi32–vi32. 1 indexed citations
8.
Kotoula, Vassiliki, Eleni Giannoulatou, Zoi Alexopoulou, et al.. (2016). Tumor infiltrating lymphocytes and hydrophobic amino acid changes in HER2-positive metastatic breast cancer.. Journal of Clinical Oncology. 34(15_suppl). 592–592.
9.
Karavasilis, Vasilios, Aristotelis Bamias, E. Razis, et al.. (2014). Prolonged efficacy of sunitinib in a cohort of patients with metastatic renal cancer: A retrospective analysis from the Hellenic Cooperative Oncology Group.. Journal of Clinical Oncology. 32(15_suppl). e15597–e15597.
10.
Karavasilis, Vasilios, Dimitrios Pectasides, Christos Papadimitriou, et al.. (2013). Safety and tolerability of adjuvant dose dense chemotherapy in elderly patients with node-positive early breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 1093–1093. 1 indexed citations
11.
Kronenwett, Ralf, Eleni Timotheadou, Ralph M. Wirtz, et al.. (2010). Evaluation of the prognostic value of UBE2C mRNA levels in early breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 10570–10570. 1 indexed citations
12.
Razis, E., Panagiotis Selviaridis, John Fletcher, et al.. (2007). Biochemical evidence of tumor response and measurable levels of the drug in glioblastoma tissue from patients treated with imatinib. Journal of Clinical Oncology. 25(18_suppl). 2023–2023. 5 indexed citations
13.
Briasoulis, Evangelos, D. Papamichael, Christos Christodoulou, et al.. (2007). Predictive value of EGFR mRNA levels assessed by quantitative RT-PCR in primary tumors of patients treated with cetuximab for metastatic colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 4121–4121. 1 indexed citations
14.
Fountzilas, George, Anna Kalogera‐Fountzila, Maria Karina, et al.. (2007). Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.. PubMed. 26(6C). 4675–86. 20 indexed citations
15.
Razis, E., Evangelos Briasoulis, Ioannis V. Kostopoulos, et al.. (2006). Predictive markers for the treatment of colorectal cancer with cetuximab. Journal of Clinical Oncology. 24(18_suppl). 13500–13500. 1 indexed citations
16.
Skarlos, Dimosthenis, Haralabos P. Kalofonos, George Fountzilas, et al.. (2005). Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.. PubMed. 25(4). 3103–8. 20 indexed citations
17.
Kosmidis, P., Gerasimos Aravantinos, D. Bafaloukos, et al.. (2004). Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer. Journal of Clinical Oncology. 22(14_suppl). 829–829. 3 indexed citations
18.
Kosmidis, P., Gerasimos Aravantinos, D. Bafaloukos, et al.. (2004). Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer. Journal of Clinical Oncology. 22(14_suppl). 829–829. 2 indexed citations
19.
Razis, E. & George Fountzilas. (2003). Technology evaluation: TriGem, Titan.. PubMed. 5(2). 204–7. 1 indexed citations
20.
Razis, E., Perry Cook, Abraham Mittelman, & Tauseef Ahmed. (1994). Treatment of Gancyclovir Resistant Cytomegalovirus with Foscarnet: a Report of Two Cases Occurring After Bone Marrow Transplantation. Leukemia & lymphoma. 12(5-6). 477–480. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birutė Brasiūnienė Breakdown of academic impact, for papers by Alvaro G. Menendez Breakdown of academic impact, for papers by A. Winship Breakdown of academic impact, for papers by A. Poveda Velasco Breakdown of academic impact, for papers by Ariel Ann Nelson Breakdown of academic impact, for papers by Usama Al‐Jumaily Breakdown of academic impact, for papers by Antoine Martin Breakdown of academic impact, for papers by Claire Briandet
Rankless by CCL
2026